The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy
Abstract
Among various nanoparticles, superparamagnetic iron oxide nanoparticles (SPIONs) have been increasingly studied for their excellent superparamagnetism, magnetic heating properties, and enhanced magnetic resonance imaging (MRI). The conjugation of SPIONs with drugs to obtain delivery nanosystems has several advantages including magnetic targeted functionalization, in vivo imaging, magnetic thermotherapy, and combined delivery of anticancer agents. To further increase the targeting efficiency of drugs through a delivery nanosystem based on SPIONs, additional targeting moieties including transferrin, antibodies, aptamers, hyaluronic acid, folate, and targeting peptides are coated onto the surface of SPIONs. Therefore, this review summarizes the latest progresses in the conjugation of targeting molecules and drug delivery nanosystems based on SPIONs, especially focusing on their performances to develop efficient targeted drug delivery systems for tumor therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Lee, J.-H., Huh, Y.-M., Jun, Y.-W., Seo, J.-W., Jang, J.-T., Song, H.-T., Kim, S., Cho, E.-J., Yoon, H.-G., Suh, J.-S., et al. (2007) · Nature Medicine · doi:10.1038/nm1467 · Cited by 1,897
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1886 · Cited by 1,863
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Superparamagnetic graphene oxide–Fe3O4 nanoparticles hybrid for controlled targeted drug carriers
Yang, X., Zhang, X., Ma, Y., Huang, Y., Wang, Y., & Chen, Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b821416f · Cited by 1,046
Papadopoulos, N., Martin, J., Ruan, Q., Rafique, A., Rosconi, M. P., Shi, E., Pyles, E. A., Yancopoulos, G. D., Stahl, N., & Wiegand, S. J. (2012) · Angiogenesis · doi:10.1007/s10456-011-9249-6 · Cited by 1,037
Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C. (2007) · Nano Letters · doi:10.1021/nl071546n · Cited by 1,036
Magnetic nanoparticles for theragnostics
Shubayev, V. I., Pisanic, T. R., & Jin, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.007 · Cited by 1,028
Kim, J., Piao, Y., & Hyeon, T. (2009) · Chem. Soc. Rev. · doi:10.1039/b709883a · Cited by 1,024
Holmes, K., Roberts, O. L., Thomas, A. M., & Cross, M. J. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.013 · Cited by 1,020
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Chen, Q., Wang, C., Zhang, X., Chen, G., Hu, Q., Li, H., Wang, J., Wen, D., Zhang, Y., Lu, Y., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0319-4 · Cited by 1,010
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Lactoferrin: a general review.
Levay, P., & Viljoen, M. (1995) · PubMed · Cited by 769
Kim, D., Jeong, Y. Y., & Jon, S. (2010) · ACS Nano · doi:10.1021/nn901877h · Cited by 726
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Magnetic nanoparticles and targeted drug delivering
Chomoucka, J., Drbohlavova, J., Huska, D., Adam, V., Kizek, R., & Hubalek, J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.014 · Cited by 646
Yan, Y., Zuo, X., & Wei, D. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0048 · Cited by 633
Nahta, R., Hung, M.-C., & Esteva, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3856 · Cited by 607
The transferrin receptor: role in health and disease
Ponka, P., & Lok, C. N. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00070-9 · Cited by 595
HER2 testing in gastric cancer: a practical approach
Rüschoff, J., Hanna, W., Bilous, M., Hofmann, M., Osamura, R. Y., Penault-Llorca, F., van de Vijver, M., & Viale, G. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.198 · Cited by 595
Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas
Veiseh, O., Sun, C., Gunn, J., Kohler, N., Gabikian, P., Lee, D., Bhattarai, N., Ellenbogen, R., Sze, R., Hallahan, A., et al. (2005) · Nano Letters · doi:10.1021/nl0502569 · Cited by 564
The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy
Mitri, Z., Constantine, T., & O'Regan, R. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/743193 · Cited by 519
Nanoparticles that communicate in vivo to amplify tumour targeting
Park, J., Lin, K., Singh, N., Schwöppe, C., Mesters, R. M., Berdel, W. E., Ruoslahti, E. I., Sailor, M. J., von Maltzhan, G., & Bhatia, S. N. (2010) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 500
Hyaluronan–CD44 interactions as potential targets for cancer therapy
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494
Multimodality Molecular Imaging of Tumor Angiogenesis
Cai, W., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045922 · Cited by 494
Sonvico, F., Mornet, S., Vasseur, S., Dubernet, C., Jaillard, D., Degrouard, J., Hoebeke, J., Duguet, E., Colombo, P., & Couvreur, P. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050050z · Cited by 484
Biomimetic amplification of nanoparticle homing to tumors
Simberg, D., Duza, T., Park, J. H., Essler, M., Pilch, J., Zhang, L., Derfus, A. M., Yang, M., Hoffman, R. M., Bhatia, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610298104 · Cited by 471
Utilizing the folate receptor for active targeting of cancer nanotherapeutics
Zwicke, G. L., Ali Mansoori, G., & Jeffery, C. J. (2012) · Nano Reviews · doi:10.3402/nano.v3i0.18496 · Cited by 458
Laurent, S., Saei, A. A., Behzadi, S., Panahifar, A., & Mahmoudi, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.924501 · Cited by 445
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.017 · Cited by 444
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Yang, X., Hong, H., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Xiao, Y., Yang, Y., Zhang, Y., Nickles, R. J., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.006 · Cited by 436
Xie, J., Chen, K., Lee, H.-Y., Xu, C., Hsu, A. R., Peng, S., Chen, X., & Sun, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802003h · Cited by 419
Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., & Gu, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4058com · Cited by 419
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Ruoslahti, E. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 419
Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2
Deshane, J., Garner, C. C., & Sontheimer, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205662200 · Cited by 415
Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.
Johnson, V. G., Schlom, J., Paterson, A. J., Bennett, J., Magnani, J. L., & Colcher, D. M. (1986) · PubMed · Cited by 406
Smart Nanocarrier Based on PEGylated Hyaluronic Acid for Cancer Therapy
Choi, K. Y., Yoon, H. Y., Kim, J.-H., Bae, S. M., Park, R.-W., Kang, Y. M., Kim, I.-S., Kwon, I. C., Choi, K., Jeong, S. Y., et al. (2011) · ACS Nano · doi:10.1021/nn202070n · Cited by 399
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
van der Meel, R., Vehmeijer, L. J. C., Kok, R. J., Storm, G., & van Gaal, E. V. B. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.012 · Cited by 398
Yang, L., Mao, H., Wang, Y. A., Cao, Z., Peng, X., Wang, X., Duan, H., Ni, C., Yuan, Q., Adams, G., et al. (2009) · Small · doi:10.1002/smll.200800714 · Cited by 356
Nanotechnology approaches for inhalation treatment of lung diseases
Kuzmov, A., & Minko, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.024 · Cited by 352
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
Agemy, L., Friedmann-Morvinski, D., Kotamraju, V. R., Roth, L., Sugahara, K. N., Girard, O. M., Mattrey, R. F., Verma, I. M., & Ruoslahti, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114518108 · Cited by 347
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Lee, H., Yu, M. K., Park, S., Moon, S., Min, J. J., Jeong, Y. Y., Kang, H.-W., & Jon, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072210i · Cited by 330
In Vivo MRI Detection of Gliomas by Chlorotoxin‐Conjugated Superparamagnetic Nanoprobes
Sun, C., Veiseh, O., Gunn, J., Fang, C., Hansen, S., Lee, D., Sze, R., Ellenbogen, R. G., Olson, J., & Zhang, M. (2008) · Small · doi:10.1002/smll.200700784 · Cited by 329
Yang, X., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Matson, V. Z., Steeber, D. A., & Gong, S. (2010) · ACS Nano · doi:10.1021/nn101670k · Cited by 322
Lee, Y., Lee, H., Kim, Y. B., Kim, J., Hyeon, T., Park, H., Messersmith, P. B., & Park, T. G. (2008) · Advanced Materials · doi:10.1002/adma.200800756 · Cited by 321
Wang, A. Z., Bagalkot, V., Vasilliou, C. C., Gu, F., Alexis, F., Zhang, L., Shaikh, M., Yuet, K., Cima, M. J., Langer, R., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800091 · Cited by 312
Peptide-Based Probes for Targeted Molecular Imaging
Lee, S., Xie, J., & Chen, X. (2010) · Biochemistry · doi:10.1021/bi901135x · Cited by 310
Gupta, A. K., & Curtis, A. S. G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.095 · Cited by 302
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide
McAteer, M. A., Sibson, N. R., von zur Muhlen, C., Schneider, J. E., Lowe, A. S., Warrick, N., Channon, K. M., Anthony, D. C., & Choudhury, R. P. (2007) · Nature Medicine · doi:10.1038/nm1631 · Cited by 289
Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy
Kang, T., Li, F., Baik, S., Shao, W., Ling, D., & Hyeon, T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.013 · Cited by 280
Li, J., He, Y., Sun, W., Luo, Y., Cai, H., Pan, Y., Shen, M., Xia, J., & Shi, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.011 · Cited by 265
Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics
Liang, R., Wei, M., Evans, D. G., & Duan, X. (2014) · Chem. Commun. · doi:10.1039/c4cc03118k · Cited by 262
Nuclear Targeting Dynamics of Gold Nanoclusters for Enhanced Therapy of HER2+ Breast Cancer
Wang, Y., Chen, J., & Irudayaraj, J. (2011) · ACS Nano · doi:10.1021/nn2032177 · Cited by 259
Improvement of MRI Probes To Allow Efficient Detection of Gene Expression
Högemann, D., Josephson, L., Weissleder, R., & Basilion, J. P. (2000) · Bioconjugate Chemistry · doi:10.1021/bc000079x · Cited by 259
Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy
Sadhukha, T., Wiedmann, T. S., & Panyam, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.061 · Cited by 250
Schleich, N., Po, C., Jacobs, D., Ucakar, B., Gallez, B., Danhier, F., & Préat, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.059 · Cited by 238
Aptamer-conjugated nanomaterials and their applications
Yang, L., Zhang, X., Ye, M., Jiang, J., Yang, R., Fu, T., Chen, Y., Wang, K., Liu, C., & Tan, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.002 · Cited by 226
In Vivo Targeting of Underglycosylated MUC-1 Tumor Antigen Using a Multimodal Imaging Probe
Moore, A., Medarova, Z., Potthast, A., & Dai, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3230 · Cited by 226
Yu, M. K., Kim, D., Lee, I., So, J., Jeong, Y. Y., & Jon, S. (2011) · Small · doi:10.1002/smll.201100472 · Cited by 225
Chlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to Glioma
Kievit, F. M., Veiseh, O., Fang, C., Bhattarai, N., Lee, D., Ellenbogen, R. G., & Zhang, M. (2010) · ACS Nano · doi:10.1021/nn1008512 · Cited by 222
Xu, L., Pirollo, K. F., Tang, W.-H., Rait, A., & Chang, E. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016357 · Cited by 218
Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging
Yang, X., Grailer, J. J., Rowland, I. J., Javadi, A., Hurley, S. A., Steeber, D. A., & Gong, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.039 · Cited by 217
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
Smalley, K. S. M., Xiao, M., Villanueva, J., Nguyen, T. K., Flaherty, K. T., Letrero, R., Van Belle, P., Elder, D. E., Wang, Y., Nathanson, K. L., et al. (2009) · Oncogene · doi:10.1038/onc.2008.362 · Cited by 216
Garmy-Susini, B., Jin, H., Zhu, Y., Sung, R.-J., Hwang, R., & Varner, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23445 · Cited by 216
Schleich, N., Sibret, P., Danhier, P., Ucakar, B., Laurent, S., Muller, R. N., Jérôme, C., Gallez, B., Préat, V., & Danhier, F. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.042 · Cited by 215
Wang, Z., Qiao, R., Tang, N., Lu, Z., Wang, H., Zhang, Z., Xue, X., Huang, Z., Zhang, S., Zhang, G., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.037 · Cited by 212
Self-citationMRI-Visible Micellar Nanomedicine for Targeted Drug Delivery to Lung Cancer Cells
Guthi, J. S., Yang, S.-G., Huang, G., Li, S., Khemtong, C., Kessinger, C. W., Peyton, M., Minna, J. D., Brown, K. C., & Gao, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9001393 · Cited by 197
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Talavera, A., Friemann, R., Gómez-Puerta, S., Martinez-Fleites, C., Garrido, G., Rabasa, A., López-Requena, A., Pupo, A., Johansen, R. F., Sánchez, O., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4518 · Cited by 195
Aptamers: Molecules of great potential
Radom, F., Jurek, P. M., Mazurek, M. P., Otlewski, J., & Jeleń, F. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.04.007 · Cited by 194
Inhibition of Tumor‐Cell Invasion with Chlorotoxin‐Bound Superparamagnetic Nanoparticles
Veiseh, O., Gunn, J. W., Kievit, F. M., Sun, C., Fang, C., Lee, J. S. H., & Zhang, M. (2009) · Small · doi:10.1002/smll.200800646 · Cited by 193
Magnetic iron oxide nanoparticles for disease detection and therapy
Tong, S., Zhu, H., & Bao, G. (2019) · Materials Today · doi:10.1016/j.mattod.2019.06.003 · Cited by 190
Nanotechnology-based intelligent drug design for cancer metastasis treatment
Gao, Y., Xie, J., Chen, H., Gu, S., Zhao, R., Shao, J., & Jia, L. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.013 · Cited by 188
Veiseh, O., Kievit, F. M., Fang, C., Mu, N., Jana, S., Leung, M. C., Mok, H., Ellenbogen, R. G., Park, J. O., & Zhang, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.016 · Cited by 185
Liu, G., Shen, H., Mao, J., Zhang, L., Jiang, Z., Sun, T., Lan, Q., & Zhang, Z. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am402128s · Cited by 184
Bakhtiary, Z., Saei, A. A., Hajipour, M. J., Raoufi, M., Vermesh, O., & Mahmoudi, M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.019 · Cited by 180
MRI Detection of Thrombin with Aptamer Functionalized Superparamagnetic Iron Oxide Nanoparticles
Yigit, M. V., Mazumdar, D., & Lu, Y. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7003928 · Cited by 177
Folate and antifolate pharmacology.
Kamen, B. A. (1997) · PubMed · Cited by 176
Progress in the chemotherapeutic treatment of osteosarcoma (Review)
Zhang, Y., Yang, J., Zhao, N., Wang, C., Kamar, S., Zhou, Y., He, Z., Yang, J., Sun, B., Shi, X., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.9434 · Cited by 172
Self-citationNanotechnology in the diagnosis and treatment of lung cancer
Cryer, A. M., & Thorley, A. J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.010 · Cited by 172
Nanoparticle-induced vascular blockade in human prostate cancer
Agemy, L., Sugahara, K. N., Kotamraju, V. R., Gujraty, K., Girard, O. M., Kono, Y., Mattrey, R. F., Park, J.-H., Sailor, M. J., Jimenez, A. I., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274258 · Cited by 170
Hyaluronic Acid Immobilized Magnetic Nanoparticles for Active Targeting and Imaging of Macrophages
Kamat, M., El-Boubbou, K., Zhu, D. C., Lansdell, T., Lu, X., Li, W., & Huang, X. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100354m · Cited by 170
Chen, T.-J., Cheng, T.-H., Chen, C.-Y., Hsu, S. C. N., Cheng, T.-L., Liu, G.-C., & Wang, Y.-M. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-008-0445-9 · Cited by 165
LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer Metastases
Leuschner, C., Kumar, C. S., Hansel, W., Soboyejo, W., Zhou, J., & Hormes, J. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9199-7 · Cited by 165
Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug
Kumar, M., Yigit, M., Dai, G., Moore, A., & Medarova, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2070 · Cited by 164
Targeted Delivery of Cisplatin to Lung Cancer Using ScFvEGFR-Heparin-Cisplatin Nanoparticles
Peng, X.-H., Wang, Y., Huang, D., Wang, Y., Shin, H. J., Chen, Z., Spewak, M. B., Mao, H. Z., Wang, X., Wang, Y., et al. (2011) · ACS Nano · doi:10.1021/nn202410f · Cited by 160
Antibody-Targeted Nanoparticles for Cancer Therapy
Fay, F., & Scott, C. J. (2011) · Immunotherapy · doi:10.2217/imt.11.5 · Cited by 160
Chen, M.-L., He, Y.-J., Chen, X.-W., & Wang, J.-H. (2012) · Langmuir · doi:10.1021/la303957y · Cited by 158
Hyaluronic Acid−Quantum Dot Conjugates for In Vivo Lymphatic Vessel Imaging
Bhang, S. H., Won, N., Lee, T., Jin, H., Nam, J., Park, J., Chung, H., Park, H., Sung, Y., Hahn, S. K., et al. (2009) · ACS Nano · doi:10.1021/nn900138d · Cited by 157
The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles
Lee, A. L. Z., Wang, Y., Cheng, H. Y., Pervaiz, S., & Yang, Y. Y. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.062 · Cited by 157
Advances in Alzheimer’s Diagnosis and Therapy: The Implications of Nanotechnology
Hajipour, M. J., Santoso, M. R., Rezaee, F., Aghaverdi, H., Mahmoudi, M., & Perry, G. L. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.002 · Cited by 152
Taratula, O., Garbuzenko, O. B., Savla, R., et al. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 151
Jalalian, S. H., Taghdisi, S. M., Hamedani, N. S., Moosavian, S. A., Lavaee, P., Zandkarimi, M., Ghows, N., Jaafari, M. R., Naghibi, S., Danesh, N. M., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.06.015 · Cited by 147
Zou, P., Yu, Y., Wang, Y. A., Zhong, Y., Welton, A. R., Galbán, C. J., Wang, S., & Sun, D. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100273t · Cited by 140
Fan, C., CHENG, Y.-H., Ting, C.-Y., Ho, Y.-J., Hsu, P., Liu, H.-L., & Yeh, C. (2016) · Theranostics · doi:10.7150/thno.15297 · Cited by 140
Melancon, M. P., Lü, W., Zhong, M., Zhou, M., Liang, G., Elliott, A. M., Hazle, J. D., Myers, J. N., Li, C., & Stafford, R. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.039 · Cited by 139
Yigit, M. V., Mazumdar, D., Kim, H., Lee, J. H., Odintsov, B. M., & Lu, Y. (2007) · ChemBioChem · doi:10.1002/cbic.200700323 · Cited by 136
Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells
Yang, X., Chen, Y., Yuan, R., Chen, G., Blanco, E., Gao, J., & Shuai, X. (2008) · Polymer · doi:10.1016/j.polymer.2008.06.005 · Cited by 135
PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer
Nagesh, P. K. B., Johnson, N., Boya, V. K. N., Chowdhury, P., Othman, S. F., Khalilzad-Sharghi, V., Hafeez, B. B., Ganju, A., Khan, S., Behrman, S. W., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.071 · Cited by 132
Ghadiri, M., Vasheghani‐Farahani, E., Atyabi, F., Kobarfard, F., Mohamadyar‐Toupkanlou, F., & Hosseinkhani, H. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36145 · Cited by 130
El‐Dakdouki, M. H., Zhu, D. C., El‐Boubbou, K., Kamat, M. N., Chen, J., Li, W., & Huang, X. (2012) · Biomacromolecules · doi:10.1021/bm300046h · Cited by 129
Molecular Characterization of Apocrine Salivary Duct Carcinoma
Chiosea, S. I., Williams, L., Griffith, C. C., Thompson, L. D. �., Weinreb, I., Bauman, J. E., Luvison, A., Roy, S., Seethala, R. R., & Nikiforova, M. N. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000410 · Cited by 129
pH-Sensitive siRNA Nanovector for Targeted Gene Silencing and Cytotoxic Effect in Cancer Cells
Mok, H., Omid Veiseh, A., Fang, C., Kievit, F. M., Wang, F. Y., Park, J. O., & Zhang, M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100221h · Cited by 128
Werner, M. E., Copp, J. A., Karve, S., Cummings, N. D., Sukumar, R., Li, C., Napier, M. E., Chen, R. C., Cox, A. D., & Wang, A. Z. (2011) · ACS Nano · doi:10.1021/nn203165z · Cited by 125
Kaaki, K., Hervé-Aubert, K., Chiper, M., Shkilnyy, A., Soucé, M., Benoit, R., Paillard, A., Dubois, P., Saboungi, M., & Chourpa, I. (2011) · Langmuir · doi:10.1021/la2037845 · Cited by 122
Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside
Liu, H., Zhang, J., Chen, X., Du, X., Zhang, J., Liu, G., & Zhang, W. (2016) · Nanoscale · doi:10.1039/c6nr00147e · Cited by 122
The Transferrin Receptor: Its Diagnostic Value and its Potential as Therapeutic Target
Thorstensen, K., & Romslo, I. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519309090703 · Cited by 113
Nagengast, W. B., Hooge, M. N. L., Oosting, S. F., den Dunnen, W. F. A., Warnders, F.-J., Brouwers, A. H., de Jong, J. R., Price, P., Hollema, H., Hospers, G. A. P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1088 · Cited by 113
MRI of Transgene Expression: Correlation to Therapeutic Gene Expression
Ichikawa, T., Högemann, D., Saeki, Y., et al. (2002) · Neoplasia · doi:10.1038/sj.neo.7900266 · Cited by 111
Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors
Accardo, A., Tesauro, D., & Morelli, G. (2013) · Polymer Journal · doi:10.1038/pj.2012.215 · Cited by 108
Capala, J., & Bouchelouche, K. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833f8c3a · Cited by 106
PSMA-targeting Iron Oxide Magnetic Nanoparticles Enhance MRI of Preclinical Prostate Cancer
Tse, B. W.-C., Cowin, G., Soekmadji, C., Jovanovic, L., Vasireddy, R. S., Ling, M., Khatri, A., Liu, T., Thierry, B., & Russell, P. J. (2014) · Nanomedicine · doi:10.2217/nnm.14.122 · Cited by 105
Yang, R., Fu, C., Fang, J.-Z., Xu, X., Wei, X., Tang, W., Jiang, X., & Zhang, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s121249 · Cited by 102
Kong, F., Wang, W., Xi, M., Duan, X., & Wang, Y. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80297 · Cited by 100
Hong, G., Yuan, R., Liang, B., Shen, J., Yang, X., & Shuai, X. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9180-9 · Cited by 98
Zheng, X.-C., Ren, W., Zhang, S., Zhong, T., Duan, X.-C., Yin, Y.-F., Xu, M., Hao, Y., Li, Z.-T., Li, H., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157082 · Cited by 98
Self-citationWhy Targeting PSMA Is a Game Changer in the Management of Prostate Cancer
Donin, N. M., & Reiter, R. E. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191874 · Cited by 97
Liao, C., Sun, Q., Liang, B., Shen, J., & Shuai, X. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.08.005 · Cited by 96
Actively Targeted Nanoparticles for Drug Delivery to Tumor
Bi, Y., Hao, F., Yan, G., Teng, L., Lee, R. J., & Xie, J. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666160619191853 · Cited by 93
Thomas, R. G., Moon, M. J., Lee, H., Sasikala, A. R. K., Kim, C. S., Park, I., & Jeong, Y. Y. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.06.010 · Cited by 89
Lassenberger, A., Scheberl, A., Stadlbauer, A., Stiglbauer, A., Helbich, T. H., & Reimhult, E. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12932 · Cited by 87
Zhu, J., Huang, H., Dong, S., Ge, L., & Zhang, Y. (2014) · Theranostics · doi:10.7150/thno.9663 · Cited by 85
Hu, Q., Gao, X., Kang, T., Feng, X., Jiang, D., Tu, Y., Song, Q., Yao, L., Jiang, X., Chen, H., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.001 · Cited by 82
Zou, P., Xu, S., Povoski, S. P., Wang, A., Johnson, M., Martin, E. W., Subramaniam, V. V., Xu, R. X., & Sun, D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000052 · Cited by 82
Yoffe, S., Leshuk, T. M. C., Everett, P., & Gu, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143707 · Cited by 82
Kiessling, F. M., Huppert, J., Zhang, C., Jayapaul, J., Zwick, S., Woenne, E. C., Mueller, M. M., Zentgraf, H., Eisenhut, M., Addadi, Y., et al. (2009) · Radiology · doi:10.1148/radiol.2532081815 · Cited by 81
Dinda, A. K., Kumar, M., Singh, Arora, Mewar, Sharma, Jagannathan, N. R., Sapra, S., Dinda, A. K., Kharbanda, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32694 · Cited by 80
Targeted Drug Delivery to Hepatocarcinoma In vivo by Phage-Displayed Specific Binding Peptide
Du, B., Han, H., Wang, Z., Kuang, L., Wang, L., Yu, L., Wu, M., Zhou, Z., & Qian, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0339 · Cited by 80
Mao, H., Chen, H., Wang, L., Yu, Q., Qian, W., Tiwari, D., Yi, H. L., Wang, A., Huang, J., & Yang, L. P. H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s49069 · Cited by 80
Chang, Y., Liu, Y., Ho, J. H., Hsu, S., & Lee, O. K. (2012) · Journal of Orthopaedic Research® · doi:10.1002/jor.22088 · Cited by 79
Gadolinium‐Doped Iron Oxide Nanoprobe as Multifunctional Bioimaging Agent and Drug Delivery System
Zhang, G., Du, R., Zhang, L., Cai, D., Sun, X. J., Zhou, Y., Zhou, J., Qian, J., Zhong, K., Zheng, K., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201502868 · Cited by 79
Li, Y., Dong, M., Fan-min, K., & Zhou, J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.028 · Cited by 78
Fakih, M., & Wong, R. (2010) · Current Oncology · doi:10.3747/co.v17is1.616 · Cited by 76
Toma, A., Otsuji, E., Kuriu, Y., Okamoto, K. K., Ichikawa, D., Hagiwara, A., Ito, H., Nishimura, T., & Yamagishi, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602668 · Cited by 75
Targeted folic acid‐PEG nanoparticles for noninvasive imaging of folate receptor by MRI
Chen, T., Cheng, T., Hung, Y., Lin, K., Liu, G., & Wang, Y. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31752 · Cited by 74
A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery
Leach, J., Wang, A., Ye, K., & Jin, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030380 · Cited by 72
Chiang, C., Hu, S., Liao, B., Chang, Y., & Chen, S.-Y. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.07.009 · Cited by 71
Singh, R., Nörret, M., House, M. J., Galabura, Y., Bradshaw, M., Ho, D., Woodward, R. C., Pierre, T. G. S., Luzinov, I. A., Smith, N. M., et al. (2015) · Small · doi:10.1002/smll.201502730 · Cited by 71
Fang, K., Liu, P., Dong, S., Guo, Y., Cui, X., Zhu, X., Li, X., Jiang, L., Liu, T., & Wu, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3571 · Cited by 71
Peptide‐mediated cancer targeting of nanoconjugates
Raha, S., Paunesku, T., & Woloschak, G. E. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.121 · Cited by 70
Satpathy, M., Wang, L., Zielinski, R. J., Qian, W., Lipowska, M., Capala, J., Lee, G. Y., Xu, H. T., Wang, Y. A., Mao, H. Z., et al. (2013) · Small · doi:10.1002/smll.201301593 · Cited by 70
Assessing the in Vivo Efficacy of Doxorubicin Loaded Hyaluronan Nanoparticles
El-Dakdouki, M. H., Xia, J., Zhu, D. C., Kavunja, H., Grieshaber, J., O’Reilly, S., McCormick, J. J., & Huang, X. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am404946v · Cited by 69
Aaron, J., Oh, J., Larson, T. A., Kumar, S., Milner, T. E., & Sokolov, K. (2006) · Optics Express · doi:10.1364/oe.14.012930 · Cited by 67
Yang, C., Rait, A. S., Pirollo, K. F., Dagata, J. A., Farkas, N., & Chang, E. H. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.05.004 · Cited by 64
Abdolahi, M., Shahbazi‐Gahrouei, D., Laurent, S., Sermeus, C., Firozian, F., Allen, B., Boutry, S., & Müller, R. N. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1514 · Cited by 55
Choi, W. I., Lee, J., Kim, J., Heo, S. U., Jeong, Y. Y., Kim, Y., & Tae, G. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.009 · Cited by 55
Wang, G., Griffin, J. I., Inturi, S., Brenneman, B., Banda, N. K., Holers, V. M., Moghimi, S. M., & Simberg, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00151 · Cited by 53
Aptamer-Modified Temperature-Sensitive Liposomal Contrast Agent for Magnetic Resonance Imaging
Zhang, K., Liu, M., Tong, X., Sun, N., Zhou, L., Cao, Y., Wang, J., Zhang, H., & Pei, R. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00250 · Cited by 52
Majumdar, D., Peng, X.-H., & Shin, D. M. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791384171 · Cited by 51
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
Mehra, R. (2010) · Biologics · doi:10.2147/btt.s3050 · Cited by 50
Functional Magnetic Nanoparticles for Non-Viral Gene Delivery and MR Imaging
Xing, R., Liu, G., Zhu, J., Hou, Y., & Chen, X. S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1205-2 · Cited by 50
Akal, Z. Ü., Alpsoy, L., & BAYKAL, A. (2016) · Ceramics International · doi:10.1016/j.ceramint.2016.02.166 · Cited by 50
Poller, W. C., Pieber, M., Boehm‐Sturm, P., Ramberger, E., Karampelas, V., Möller, K., Schleicher, M., Wiekhorst, F., Löwa, N., Wagner, S., et al. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.07.013 · Cited by 49
Duan, L., Yang, F., He, W. J., Song, L., Qiu, F., Xu, N., Xu, L., Zhang, Y., Hua, Z., & Gu, N. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603637 · Cited by 48
A Tumor-Targeted Nanodelivery System to Improve Early MRI Detection of Cancer
Pirollo, K. F., Dagata, J. A., Wang, P. C., Freedman, M. T., Vladár, A. E., Fricke, S. T., Ileva, L. V., Zhou, Q., & Chang, E. H. (2006) · Molecular Imaging · doi:10.2310/7290.2006.00005 · Cited by 48
Akal, Z. Ü., Alpsoy, L., & BAYKAL, A. (2016) · Applied Surface Science · doi:10.1016/j.apsusc.2016.03.217 · Cited by 46
Lin, R., Huang, J., Wang, L., Li, Y., Lipowska, M., Wu, H. C., Yang, J., & Mao, H. Z. (2018) · Biomaterials Science · doi:10.1039/c8bm00225h · Cited by 46
Self-citationA GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
Zhao, M., Liu, Z., Dong, L., Zhou, H., Yang, S., Wu, W., & Lin, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168268 · Cited by 46
Magnetic Nanoparticles Enhance Adenovirus Transduction In Vitro and In Vivo
Sapet, C., Pellegrino, C., Laurent, N., Sicard, F., & Zelphati, O. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0629-9 · Cited by 45
Simberg, D., Zhang, W.-M., Merkulov, S. M., McCrae, K. R., Park, J., Sailor, M. J., & Ruoslahti, E. I. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.035 · Cited by 44
A folate-integrated magnetic polymer micelle for MRI and dual targeted drug delivery
Ao, L., Bi, W., Liu, P., Huang, L., Yue, C., Gao, D., Wu, C., & Su, W. (2014) · Nanoscale · doi:10.1039/c4nr02484b · Cited by 44
Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand
Kulhari, H., Pooja, D., Rompicharla, S. V. K., Sistla, R., & Adams, D. J. (2015) · Medicinal Research Reviews · doi:10.1002/med.21345 · Cited by 41
HER-2 as a Target for Breast Cancer Therapy
Ignatiadis, M., Desmedt, C., Sotiriou, C. P., de Azambuja, E., & Piccart, M. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1844 · Cited by 41
Yang, R., Fu, C., Li, N., Wang, L., Xu, X., Yang, D.-Y., Fang, J.-Z., Jiang, X., & Zhang, L. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.09.038 · Cited by 40
Kawamura, W., Miura, Y., Kokuryo, D., Toh, K., Yamada, N., Nomoto, T., Matsumoto, Y., Sueyoshi, D., Liu, X., Aoki, I., et al. (2015) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/16/3/035004 · Cited by 39
Solar, P., González, G., Vilos, C., Herrera, N., Juica, N., Moreno, M., Simón, F., & Velásquez, L. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0077-5 · Cited by 39
Critical appraisal of trastuzumab in treatment of advanced stomach cancer
Meza–Junco, J., Au, H., & Sawyer, M. B. (2011) · Cancer Management and Research · doi:10.2147/cmar.s12698 · Cited by 38
MR molecular imaging of HER‐2 in a murine tumor xenograft by SPIO labeling of anti‐HER‐2 affibody
Kinoshita, M., Yoshioka, Y., Okita, Y., Hashimoto, N., & Yoshimine, T. (2010) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.363 · Cited by 37
Thaler, S., Fiedorowicz, M., Chorągiewicz, T., Bolz, S., Tura, A., Henke‐Fahle, S., Yoeruek, E., Zrenner, E., Bartz‐Schmidt, K., Ziemssen, F., et al. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.01927.x · Cited by 37
The Energy Landscape of a Selective Tumor-Homing Pentapeptide
Zanuy, D., Flores‐Ortega, A., Casanovas, J., Curcó, D., Nussinov, R., & Alemán, C. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp711477k · Cited by 36
Magnetic carbon nanotubes with particle-free surfaces and high drug loading capacity
Vermisoglou, E. C., Pilatos, G., Romanos, G. E., Devlin, E., Kanellopoulos, N. K., & Karanikolos, G. N. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/35/355602 · Cited by 36
Lu, C., Ji, J., Zhu, X., Tang, P., Zhang, Q., Zhang, N., Wang, Z., Wang, X., Chen, W.-Q., Hu, J., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09879 · Cited by 36
Xu, Y., Yan, Wu, Feng, Chen, M., Liu, Hao, Yang, Y., Zhang, Lin, et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38678 · Cited by 34
Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles
Gao, H., Yang, Z. H., Zhang, S., Pang, Z., & Jiang, X. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.886038 · Cited by 34
Self-citationWang, X., Li, B., Li, R., Yang, Y., Zhang, H., Tian, B., Cui, L., Weng, H., & Wei, F. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.09.175 · Cited by 34
Liang, B., Li, Li, Yi, & Chen, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s45767 · Cited by 32
Fang, L., Holford, N. H. G., Hinkle, G. H., Cao, X., Xiao, J. J., Bloomston, M., Gibbs, S. T., Saif, O. H. A., Dalton, J. T., Chan, K. K., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006293758 · Cited by 32
Zhang, C., Yan, Y., Zou, Q., Chen, J., & Li, C. (2015) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12437 · Cited by 31
Peptide-based cationic liposome-mediated gene delivery
Zhao, Y., Zhang, S., Cui, S., Wang, B., & Zhang, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.630387 · Cited by 30
Self-citationSatake, N., Duong, C., Chen, C. Y.-H., Barisone, G. A., Díaz, E., Tuscano, J. M., Rocke, D. M., Nolta, J. A., & Nitin, N. (2014) · British Journal of Haematology · doi:10.1111/bjh.13066 · Cited by 30
Effects of a monoclonal anti-αvβ3 integrin antibody on blood vessels—A pharmacodynamic study
Zhang, D., Pier, T., McNeel, D. G., Wilding, G., & Friedl, A. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9013-8 · Cited by 30
Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA
Zhi, D., Zhao, Y., Cui, S., Chen, H., & Zhang, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.03.048 · Cited by 28
Self-citationLi, D., Tan, J.-E., Tian, Y., Huang, S., Sun, P., Wang, M., Han, Y., Li, H., Wu, H., Zhang, X., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.010 · Cited by 27
Chen, H.-L., Hsu, F., Kao, Y. C. J., Liu, H. S., Huang, W. Z., Lu, C. F., Tsai, P. H., Ali, A., Lee, G. A., Chen, R. J., et al. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0313-2 · Cited by 27
Rogers, B. E., Roberson, P. L., Shen, S., Khazaeli, M. B., Carpenter, M., Yokoyama, S., Brechbiel, M. W., LoBuglio, A. F., & Buchsbaum, D. J. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.502 · Cited by 25
Yuan, Y., He, Y., Bo, R., Ma, Z., Wang, Z., Dong, L., Lin, T., Xue, X., & Li, Y. (2018) · Nanoscale · doi:10.1039/c8nr05141k · Cited by 24
Wang, X., Chang, Y., Zhang, D., Tian, B., Yang, Y., & Wei, F. (2016) · RSC Advances · doi:10.1039/c6ra20903c · Cited by 20
Zhao, Y., Yao, Q., Tan, H., Wu, B., Hu, P., Wu, P., Gu, Y., Zhang, C., Cheng, D., & Shi, H. (2013) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-013-2846-7 · Cited by 17
Liu, D., Chen, C., Hu, G., Mei, Q., Qiu, H., Long, G., & Hu, G. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr010 · Cited by 17
Kl, W. (2001) · PubMed · Cited by 14
Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents
Pu, F., Xue, S., Qiao, J., et al. (2016) · Current Protein and Peptide Science · doi:10.2174/1389203717666160101123725 · Cited by 10
Dolatyari, M., Rostami, A., Torabi, P., & Klein, A. (2017) · Zeitschrift für anorganische und allgemeine Chemie · doi:10.1002/zaac.201700257 · Cited by 6
Cited by
Zhi, D., Yang, T., O'Hagan, J., Zhang, S., & Donnelly, R. F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.032 · Cited by 637
Self-citationRecent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review
Khan, M. I., Hossain, M. I., Hossain, M. K., Rubel, M. H. K., Hossain, K. M., Mahfuz, A. M. U. B., & Anik, M. I. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00002 · Cited by 370
Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
Zhang, J., Ji, C., Zhang, H., Shi, H., Mao, F., Qian, H., Xu, W., Wang, D., Pan, J., Fang, X., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8207 · Cited by 265
Magnetic Nanoparticles as MRI Contrast Agents
Avasthi, A., Caro, C., Pozo-Torres, E., Leal, M. P., & García-Martín, M. L. (2020) · Topics in Current Chemistry · doi:10.1007/s41061-020-00302-w · Cited by 253
Gupta, R., Chauhan, A., Kaur, T., Kuanr, B. K., & Sharma, D. (2022) · Nanoscale · doi:10.1039/d2nr02210a · Cited by 35
Metadata
- Authors
- Zhi, D., Yang, T., Yang, J., Fu, S., & Zhang, S.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 102
- Pages
- 13-34
- ISSN
- 1742-7061 (ISSN-L)
- OpenAlex
- W2990574737
- Cited by
- 283
- References
- 199
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.